Methylone
| MDMC | |
|---|---|
| Salts [] | |
|---|---|
| Methylone hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 207.23 g/mol [1] |
| Predicted LogP | 0.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H13NO3 |
| IUPAC name | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one |
| SMILES | CC(C(=O)C1=CC2=C(C=C1)OCO2)NC |
| InChI | InChI=1S/C11H13NO3/c1-7(12-2)11(13)8-3-4-9-10(5-8)15-6-14-9/h3-5,7,12H,6H2,1-2H3 |
| InChIKey | VKEQBMCRQDSRET-UHFFFAOYSA-N |
| CAS number | 186028-79-5 |
| UNII | L4I4B1R01F |
| PubChem CID | 45789647 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 0.5 hours |
| Elimination half-life | 5.8–6.9 hours[3] |
| Duration of action | 2–3.5 hours |
| Metabolism | CYP2D6, CYP1A2, CYP2B6, and CYP2C19, COMT. [https://www.researchgate.net/figure/Common-routes-of-metabolism-for-methylone-3-Hydroxy-4-methoxy-N-methylcathinone-and_fig3_326760071] |
| Routes of administration | Common: oral, insufflation, Uncommon: <abbr title="Intravenous">IV</abbr> or <abbr title="Intramuscular">IM</abbr> injection, rectal |
Methylone (also known as 2-Methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one, Bk-mdma, 3,4-Methylenedioxy-N-methylcathinone, Methylenedioxymethcathinone, J899.632f, β-keto-3,4-methylenedioxymethamphetamine, 3,4-methylenedioxy-N-methylcathinonmethylone, 1-Propanone, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)-, βK-MDMA or M1 (psychedelic)) is a substance of the 3,4-methylenedioxyphenethylamine and cathinone class.
Chemistry
Salts []
Stereochemistry []
Methylone is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Methylone matches Lipinski's rule of five.Reagents
There are currently 14 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | bright yellow | |
| Mecke | Yellow -> Orange | |
| Mandelin | yellow/green > brown | |
| Liebermann | yellow > black | |
| Froehde | bright yellow | |
| Robadope | grey / brown | |
| Simon's | faint blue | |
| Ehrlich | no color change | |
| Hofmann | no color change | |
| Scott | no color change | |
| Morris | pale green | |
| Zimmermann | dark violet after 5 minutes | |
| Gallic | yellow | |
| Folin | no color change |
Pharmacology
Mechanism of action []
A reproducible, simple, and small-scale method for determining the re-uptake and release of monoamines (dopamine, serotonin (5-HT) and norepinephrine) using rat brain synaptosomes /was developed/. These assays were then applied to study the effects of different kinds of non-medically used psychoactive drugs on monoamine re-uptake and release. The phenethylamine derivatives, 4-fluoroamphetamine, 2-methylamino-3,4-methylene-dioxy-propiophenone (methylone), 1-(1,3-benzodioxol-5-yl)-2-butanamine (BDB), and N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB), had strong inhibitory effects on the re-uptake of dopamine, 5-HT and norepinephrine. 4-Fluoroamphetamine, methylone and BDB also strongly increased the release of the three monoamines, but MBDB increased 5-HT and norepinephrine release, but had little effect on dopamine release. However, 2,5-dimethoxy-4-iodophenethylamine (2C-I), 2,5-dimethoxy-4-ethylphenethylamine (2C-E), 2,5-dimethoxy-4-chlorophenethylamine (2C-C), 2,4,5-trimethoxyamphetamine (TMA-2) and 2,4,6-trimethoxyamphetamine (TMA-6), which are methoxylated phenethylamine derivatives, slightly influenced the re-uptake and release of monoamines. Alpha-metyltryptamine (AMT), a tryptamine derivative, was one of the strongest re-uptake inhibitors and releasers of the three monoamines. The tryptamine derivative, 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), also strongly inhibited re-uptake and increased the release of the three monoamines. N,N-dipropyltryptamine (DPT), 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), 5-methoxy-N,N-methylisopropyltryptamine (5-MeO-MIPT), and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) inhibited monoamine re-uptake, but had a few effects on monoamine release. 1-(3-Chlorophenyl)piperazine (3CPP) and 1-(methoxyphenyl)piperazine (4MPP), which are piperazine derivatives, inhibited monoamine re-uptake and accelerated their release. The results suggest that some designer drugs strongly act on the central nerve system to the same extent as restricted drugs. [1]
Experience reports
Erowid
There are currently 30 experience reports involving methylone on Erowid: []- "After the Initial Tsunami Wave" by Murple
- "Just Like MDMA, Then..." by Double Trouble
- "A Seeker's Best Friend" by Clear Fire
- "A New Sunday Morning Sacrament" by ChemicalBilly
- "Dancing for the First Time" by The Loin Speaks
- "Sheer Perfection" by mensaman
- "Pain, Arrhythmias, Hospital Stay" by stbot32
- "You Held Me Tight" by stwanky
- "Going Up is Better When you're Down" by Speaker
- "Ego Death" by Andrew
- "A Comparison" by potty
- "Unexpected Synergy or Simply Too Much" by Anonymous
- "Cirque Du Phenethylamines" by Sequinned
- "First Time with Small Doses" by Winkles
- "The Perfect Evening, The Perfect Substance" by WhatNot
- "The Artful Dodger" by Nalibilan
- "Explosion Is Not Like MDMA" by anonymous
- "The Feeling Within" by Sepulfreak
- "Rockets, Pillows and Waves" by The Flow
- "Euphoric and Extremely Peaceful" by open
- "Breathing Better With the Letter B" by nanobrain
- "A Gift from God" by Squirrel
- "In the Name of Science; Definitely Not Worth It" by MMan
- "My First Day of Spring" by Treefingers
- "Magic Doesn't Return?" by MthylnMan
- "Methylone has Addictive Properties" by MthylnMan
- "Subtle and Satisfying" by Cerebronaut
- "Tranquility" by Matt Himself
- "Pressing Buttons" by Johnny Lemonhead
- "2cBwildered" by Spinal
- "2gs Golden Teachers and 72mg 5-MAPB + hordenine: Incredibly healing and profoundly blissful experience" by COVID19_In_My_ANUS (9 upvotes)
- "My first Heroic Dose of LSD (Long post, on a lil Adderall and still vibing from this experience)" by terrapincaboose (7 upvotes)
- "There are 45 psychedelic and dissociative trip reports in the Drug Users Bible: Download a free copy from here. Whether psychedelics are used for recreation, you need to look after yourself. Stay safe." by DMTrott (3 upvotes)
Legal status []
- Australia: Methylone is a Schedule 9.
- Brazil: Methylone is a F2.[4]
- Canada: Methylone is a Schedule I.
- United Kingdom: Methylone is a Class B under the "Misuse of Drugs Act 1971".
- United States: Methylone is a Schedule I under the "Controlled Substances Act".
- Germany: Methylone is a Anlage II under the "Betäubungsmittelgesetz (BtMG)".
- United Nations: Methylone is a Schedule II [https://www.unodc.org/LSS/Substance/Details/40f647f3-b96c-4a7a-8139-88c0ff651983].
- Other: Methylone is a <small></small>: I-P, SE: Förteckning I.[5][6]
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 45789647, Methylone. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/45789647
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methylone. UNII: L4I4B1R01F. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/L4I4B1R01F
Poyatos L, Lo Faro AF, Berardinelli D, Sprega G, Malaca S, Pichini S, Huestis MA, Papaseit E, Pérez-Mañá C, Busardò FP, Farré M. Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans. International Journal of Molecular Sciences. November 2022; 23(23). PMID 36498963. https://doi.org/10.3390/ijms232314636
RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
Ustawa z dnia 15 kwietnia 2011 r. o zmianie ustawy o przeciwdziałaniu narkomanii ( Dz.U. 2011 nr 105 poz. 614 ). Internetowy System Aktów Prawnych. http://isap.sejm.gov.pl/DetailsServlet?id=WDU20111050614
Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika. Läkemedelsverket. https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 10:54:33 |
| drugspro | ok | 2026-11-20 10:54:29 |
| erowid | ok | 2026-11-20 10:54:35 |
| gsrs | ok | 2026-11-20 10:54:30 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0254656) | 2026-11-20 10:54:29 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 10:54:33 |
| pubchem | ok | 2026-11-20 10:54:27 |
| ok | 2026-11-20 10:54:29 | |
| sider | missing (not in SIDER) | 2026-11-20 10:54:29 |
| structure | ok | 2026-11-20 10:54:29 |
| wikipedia | ok | 2026-11-20 10:54:29 |